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ence over reward learning has proven
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serotonin function have minimal abuse li-
ability, laboratory rats will work vigor-
ously to earn electrical stimulation of the
dorsal raphe nucleus. In this study,
McDevitt et al. explore nonserotonergic
cell populations of the dorsal raphe nu-
cleus, examining their ability to reinforce
behavior and control the firing ofmidbrain
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The dorsal raphe nucleus (DRN) contains the largest
group of serotonin-producing neurons in the brain
and projects to regions controlling reward. Although
pharmacological studies suggest that serotonin
inhibits reward seeking, electrical stimulation of
the DRN strongly reinforces instrumental behavior.
Here, we provide a targeted assessment of the
behavioral, anatomical, and electrophysiological
contributions of serotonergic and nonserotonergic
DRN neurons to reward processes. To explore DRN
heterogeneity, we used a simultaneous two-vector
knockout/optogenetic stimulation strategy, as well
as cre-induced and cre-silenced vectors in several
cre-expressing transgenic mouse lines. We found
that the DRN is capable of reinforcing behavior pri-
marily via nonserotonergic neurons, for which the
main projection target is the ventral tegmental area
(VTA). Furthermore, these nonserotonergic projec-
tions provide glutamatergic excitation of VTA dopa-
mine neurons and account for a large majority of
theDRN-VTApathway. These findings help to resolve
apparent discrepancies between the roles of sero-
tonin versus the DRN in behavioral reinforcement.INTRODUCTION
Dopaminergic neurons of the ventral tegmental area (VTA) play a
central role in reward learning (Wise, 2004).Whole-brainmapping
studieshave found thegreatestdensity ofVTA-projectingneurons
to reside in the dorsal raphe nucleus (DRN) (Phillipson, 1979; Wa-
tabe-Uchida et al., 2012). The DRN contains the largest group of
serotonin neurons in the brain and supplies the vast majority of
ascending serotonergic projections (Jacobs and Azmitia, 1992).Cell ReThe role of the DRN in reinforcement learning is unclear, with
literature suggesting both excitatory and inhibitory functions.
For example, electrical stimulationof theDRN issufficient tovigor-
ously reinforce instrumental behavior in rats (Corbett and Wise,
1979; Margules, 1969; Rompre´ and Miliaressis, 1985; Simon
et al., 1976; Van Der Kooy et al., 1978). In contrast, drugs that
selectively elevate levels of serotonin, the major neurotransmitter
output of the DRN, possess very low abuse liability in humans and
arenot self-administered in laboratory animals (Go¨testamandAn-
dersson, 1975; Griffiths et al., 1976; Zawertailo et al., 1995).
A recent study provided evidence that optogenetic stimulation
of serotonergic DRN cell bodies is capable of reinforcing instru-
mental behavior (Liu et al., 2014). However, a majority of the
rewarding effects of electrical DRN stimulation act through fibers
with refractory periods that are too rapid to be of serotonergic
origin (Rompre´ and Miliaressis, 1987). These studies suggest
that the DRN contains a population of nonserotonergic fibers
capable of reinforcing behavior to a greater degree than seroto-
nin-producing neurons. However, it is not known whether these
fibers originate from neuronswithin the DRN or instead represent
axons of distal cell bodies projecting to or through the DRN.
Given recent demonstrations that DRN projection neurons
are heterogeneous and include serotonergic, dopaminergic,
GABAergic, and nonserotonergic glutamate populations (re-
viewed in Vasudeva et al., 2011), we explored the participation
of these populations in reward circuitry and reinforcement
learning. By testing self-stimulation behavior, anterograde/retro-
grade tracing, and electrophysiology, we found that the DRN re-
inforcesbehaviorpreferentially throughnonserotonergicneurons,
which make up the majority of the DRN-VTA pathway and pro-
duce strong glutamatergic excitation of VTA dopamine neurons.
RESULTS
Stimulation of Dopamine, but not Serotonin, Reinforces
Instrumental Behavior
To test whether the release of serotonin produces reward-related
behavior, we examined the ability of the serotonin-releasingports 8, 1857–1869, September 25, 2014 ª2014 The Authors 1857
Figure 1. Pharmacological Stimulation of Dopamine but Not Serotonin Release Reinforces Behavior
(A) Mice (n = 9–18 per group) were conditioned with injections of the serotonin-releasing agent fenfluramine (0–30 mg/kg, i.p.) or the dopamine-releasing agent
amphetamine (1–3 mg/kg, i.p.).
(B) Percentage of time spent in drug-paired chamber on baseline and test days. Repeated-measures ANOVA (drug 3 day) interaction F(7,96) = 4.166, p < 0.001;
**p < 0.01, ***p < 0.001 post hoc.
(C) Change in time spent on drug-paired chamber between test and baseline days. One-way ANOVA F(7,96) = 5.318, p < 0.0001; *p < 0.05, ***p < 0.001 Dunnett’s
post hoc versus saline.
(D) Self-administration experiment in a separate cohort of mice. After pretraining for sucrose, mice were implanted with intravenous catheters and allowed to self-
administer fenfluramine (0.03 mg/kg/infusion) or amphetamine (0.05 mg/kg/infusion) (n = 8 per group).
(E) Sample data from individual self-administration sessions demonstrating timing of infusions for mice with access to fenfluramine (red) and amphetamine (blue)
and during the first day of extinction training.
(F and G) Daily lever-press counts during sucrose pretraining (left y axis) and drug self-administration (right y axis). These experiment phases are plotted on
different scales because the number of maximally allowed rewards differed.
(H) Total number of lever presses during last three days of drug access. Two-way ANOVA (drug3 lever) interaction F(1,28) = 8.095, p < 0.01; ***p < 0.001 post hoc.
(I) Daily drug infusions during drug self-administration phase.
(J) Total number of drug infusions during the last 3 days of drug access, **p < 0.01.
(K) Daily counts of infusions of saline during extinction training.
(L) Total number of saline infusions during the first 2 days of extinction, *p < 0.05. Group data are presented here and in subsequent figures as mean ± SEM.agent fenfluramine to elicit a conditioned place preference and to
support self-administration in mice (Figure 1). Amphetamine,
which ismechanistically similar to fenfluramine but acts preferen-1858 Cell Reports 8, 1857–1869, September 25, 2014 ª2014 The Autially on dopaminergic reuptake sites (Rothman and Baumann,
2009), was used as a positive control. In the conditioned place
preference paradigm, none of the five doses of fenfluramine wethors
Figure 2. Optogenetic Stimulation of VTA Dopamine but Not DRN Serotonin Cell Bodies Reinforces Behavior
(A and B) Selective targeting of gene expression was achieved by injecting cre-induced (‘‘cre-ON’’) vectors expressing ChR2-eYFP or eYFP alone into the (A) DRN
of ePet-cremice or (B) VTA of THiCremice. The insets depict expression of eYFP (green), double labeled in redwith tryptophan hydroxylase (TpH) for DRN tissue or
tyrosine hydroxylase (TH) for VTA tissue. Scale bars represent 200 mm.
(C) Mice were trained to nose poke into an active port to receive 3 s trains of 20 Hz laser stimulation; nose pokes into an inactive port were not reinforced.
(D and E) Representative cumulative-activity graph and group mean nose pokes made in first behavioral session for VTA-dopamine (n = 11), DRN-serotonin
(n = 18), and a combined control group expressing eYFP in DRN or VTA (n = 17). Two-way ANOVA (group3 port) interaction F(2,86) = 8.317, p < 0.001; ***p < 0.001
post hoc.
(F) Active nose poke responding on 3 consecutive days of testing.
(G) Mice underwent a real-time place preference task in which presence in one half of a chamber triggered continuous 20 Hz laser stimulation. Example tracks for
a DRN serotonin stimulated mouse (top, red) and a VTA dopamine stimulated mouse (bottom, blue).
(H) Minute-by-minute percentage of time spent in the laser-paired half of the chamber.
(I) Overall preference for laser-paired side during 12 min session. One-way ANOVA F(2,38) = 12.05, p < 0.0001; **p < 0.01, ***p < 0.001 post hoc.
(J) Percent of laser pulses in a 20 pulse train resulting in action potentials in ChR2+ DRN serotonin cell bodies, recorded ex vivo in whole-cell current clamp. Inset,
sample trace with 20Hz stimulation (see also Figures S1 and S2).tested (0.3–30 mg/kg, intraperitoneally [i.p.]) produced a sig-
nificant preference or aversion (Figures 1A–1C). In contrast,
amphetamine (1 or 3 mg/kg, i.p.) elicited a strong preference.
Similarly, mice that had self-administration access to amphet-
amine significantly lever pressed more for drug infusions than
mice with access to fenfluramine (Figures 1D–1J). After 1 week
of drug abstinence, each group of mice was also tested for
extinction responding, inwhich lever presses resulted in saline in-
fusions. Mice with previous access to amphetamine exhibited
greater measures of drug seeking (Figures 1K and 1L).
Although serotonin release was not sufficient to strongly elicit
reward-related behavior, it is possible that such behavioral ef-
fects require precisely timed neuronal activity within DRN sero-
tonin neurons and/or corelease of other transmitters. To explore
these possibilities, we used optogenetic stimulation with theCell Relight-activated ion channel channelrhodopsin-2 (ChR2) to acti-
vate neurons in vivo (Adamantidis et al., 2007) and test whether
stimulation of serotonergic DRN cell bodies was sufficient to
reinforce behavior (Figure 2A). Compared with classical electri-
cal stimulation, this approach offers the advantages of restrict-
ing stimulation to genetically defined populations of cells
without affecting fibers of passage or terminals (Tye and Dei-
sseroth, 2012). As a positive control, we also tested stimulation
of dopaminergic VTA cell bodies (Figure 2B). Selective targeting
of ChR2 to these cells was achieved by stereotaxically injecting
cre-inducible (‘‘cre-ON’’) vectors expressing ChR2-eYFP or
eYFP alone into the DRN of ePet-cre mice or the VTA of THiCre
mice. These transgenic lines selectively express cre recombi-
nase in serotonergic and catecholaminergic neurons, respec-
tively. Nearly all (91.4%) of 1,827 total eYFP-positive DRNports 8, 1857–1869, September 25, 2014 ª2014 The Authors 1859
neurons counted from eight ePet-cre animals also tested posi-
tive for tryptophan hydroxylase, an enzyme essential for seroto-
nin synthesis. Similarly, 88.9% of 903 eYFP-positive neurons
counted from 4 THiCre animals also tested positive for tyrosine
hydroxylase, an enzyme necessary for dopamine synthesis.
Behavior from DRN and VTA-injected eYFP control mice did
not differ, and they were combined into a single group. Mice
were trained in an operant task (Figure 2C), in which nose
pokes into an active port resulted in 3 s trains of 20 Hz laser
stimulation. While stimulation of VTA dopamine neurons
strongly reinforced behavior in this task, stimulation of DRN se-
rotonin neurons had no effect (Figures 2D–2F). We found the
same pattern of results in a real-time place preference test (Fig-
ure 2G), in which presence of the mouse in one half of a cham-
ber resulted in continuous 20 Hz stimulation. Stimulation of VTA
dopamine neurons reinforced behavior in this task, whereas
stimulation of DRN serotonin neurons did not (Figures 2H and
2I). Parametric variations of laser intensity, pulse frequency,
and repeated days of training all failed to elicit statistically signif-
icant measures of reward or aversion in DRN serotonin stimu-
lated mice (Figure S1). DRN serotonin neurons were capable
of following 20 Hz optical stimulation with action potentials (Fig-
ures 2J and S2), consistent with previous demonstrations that
electrical stimulation produces increasing levels of serotonin
release at increasing frequencies up to and including 20 Hz
(Sharp et al., 1989). Together with the fenfluramine experiments,
these data demonstrate that behavioral measures of reinforce-
ment that are easily elicited by stimulation of dopamine release
are much less sensitive to serotonin.
Stimulation of Nonserotonergic DRN Neurons
Reinforces Instrumental Behavior
We next performed an experiment collectively stimulating all
nonserotonergic DRN output to test for nonserotonergic reward
mechanisms. To do this, we performed a combined knockout/
stimulation experiment in mice homozygous for a floxed allele
of Tph2, the gene encoding the rate-limiting enzyme for seroto-
nin synthesis. Tph2lox/lox mice were coinjected with a virus
mixture containing a 1:10 ratio of a vector nonspecifically ex-
pressing cre recombinase and a second cre-ON vector ex-
pressing either ChR2-eYFP or eYFP alone (Figures 3A and 3B).
Because cre-ON vector expression is dependent on cre recom-
binase, which is not endogenously expressed in thesemice, only
cells transduced by both viral vectors will express functional
ChR2 protein (Figure 3A). Although all DRN neuron types (sero-
tonin, glutamate, GABA, dopamine) will be capable of laser-acti-
vated stimulation, cre recombinase will excise the Tph2 gene,
preventing synthesis of serotonin without affecting other trans-
mitters. Indeed, only 1.3% of 1,276 total eYFP-positive DRN
neurons counted from three animals also labeled for tryptophan
hydroxylase. Optical stimulation of the DRN in these mice
strongly reinforced behavior in nose-poke and real-time place
preference tasks (Figures 3C and 3D). To test whether restora-
tion of serotonin would alter the rewarding properties of DRN
stimulation, we administered 5-hydroxytryptophan, the missing
intermediate in the serotonin synthesis pathway of ChR2-ex-
pressing neurons. To ensure an ability to detect increases or
decreases in rewarding properties of stimulation, laser pulse1860 Cell Reports 8, 1857–1869, September 25, 2014 ª2014 The Auwidths were adjusted for each mouse to deliver pulses that
were empirically determined to produce 50% of maximal behav-
ioral responding (Figure S3). Nose-poke behavior was not
affected by administration of 5-hydroxytryptophan (40 mg/kg,
i.p.) 30 min prior to testing (Figures 3E and 3F), a dose and
time point that restores serotonin function in Tph2 knockout
mice (Liu et al., 2011). Finally, to ensure that behavioral effects
were anatomically specific to the DRN, we included a control
group in which ChR2 expression was targeted anterior to the
DRN. The site of injection for anatomical control ChR2 mice
ranged from 2.9 to 3.8 mm posterior to bregma; injection sites
for DRN-targeted ChR2 mice ranged from 3.9 to 4.4 mm poste-
rior to bregma (mean difference of 0.7 mm). Optical stimulation
of neurons anterior to the DRN did not reinforce behavior (Fig-
ures 3C and 3D). These results indicate that a population of
DRN cell bodies is capable of driving reward-related behavior
in a serotonin-independent fashion.
To examine whether these effects were dependent on
dopamine signaling, we tested effects of the D1 antagonist
SCH23390 (SCH) onoptical self-stimulation behavior (Figure 3G).
On consecutive days, mice were injected 15 or 30 min prior to
testing with either saline or a dose of SCH that did not prevent
locomotion (30 mg/kg; Figure S4). To reduce intersubject vari-
ability, data from each mouse were normalized to performance
on the last day of baseline training. Regardless of injection
timing, D1 receptor blockade significantly reduced nose-poke
responses during the later period in the session, but not during
the first 5 min (Figures 3H and 3I). This pattern of responding
suggests a reduction in the rewarding effects of laser stimulation,
rather than an impaired ability to perform the nose-poke
response (Fouriezos and Wise, 1976).
Stimulation of Dopaminergic or GABAergic DRN Cell
Bodies Do Not Reinforce Instrumental Behavior
The anterior DRN contains dopaminergic neurons that are
involved in attention and arousal (Lu et al., 2006) that could
underlie dopamine-dependent, serotonin-independent DRN re-
ward. We tested this by injecting cre-ON vectors expressing
ChR2-eYFP or eYFP alone into the DRN of THiCre mice (Fig-
ure 4A). In DRN tissue from five mice, 240 of 356 eYFP-positive
cells double labeled for tyrosine hydroxylase (67.4%). While this
specificity was lower than that obtained in the VTA, similar
numbers have been reported for the specificity of GFP expres-
sion within the DRN of TH-GFP transgenic mice (Dougalis
et al., 2012), suggesting that the tyrosine hydroxylase promoter
may be active in cells expressing protein at levels below immu-
nohistochemical detection. Nevertheless, stimulation of these
cells failed to reinforce behavior in nose-poke or real-time place
preference tasks (Figures 4B–4D), which indicates that activity of
DRN dopamine neurons cannot account for the reward-related
behaviors seen previously.
Thus far, we have observed that a population of DRN neurons
is capable of reinforcing behavior, but this effect is not seen with
selective stimulation of serotonergic or dopaminergic cell types.
This suggests that the rewarding effects of DRN stimulation are
driven by GABAergic and/or glutamatergic neurons, the two re-
maining major DRN cell types. The DRN contains GABAergic
projection neurons (Bang and Commons, 2012), which couldthors
Figure 3. Optogenetic Stimulation of DRN Cell Bodies Reinforces Behavior in a Dopamine-Dependent, Serotonin-Independent Manner
(A) Left panel, schematic view of a cell transduced with cre-induced (‘‘cre-ON’’) viral vector. In the absence of cre recombinase, viral plasmid DNA remains in
antisense orientation and does not express functional protein. (Inset) Lack of eYFP signal in mouse injected with cre-ON ChR2-eYFP. (Right panel) Coinjection of
cre-ON and cre-expressing viral vectors results in knockout of floxed genomic DNA and rearrangement of viral plasmid DNA into sense orientation, resulting in
expression of ChR2-eYFP. (Inset) robust eYFP expression in mouse coinjected with cre-expressing and cre-ON viral vectors.
(B) Tph2lox/loxmicewere coinjected with viral vectors expressing cre and cre-ONChR2-eYFP or eYFP into DRN. (Insets) Whole DRN (scale bar, 200 mm) and detail
of nonoverlapping expression of eYFP (green) and tryptophan hydroxylase (TpH, red). Thus, cells with ChR2 lack the enzyme necessary for serotonin synthesis.
An additional anatomical control group was coinjected with cre and cre-ON ChR2-eYFP 0.7 mm anterior to the DRN.
(C) Nose pokes during first day of self-stimulation testing for nonserotonergic DRN stimulation (n = 10), anterior controls (n = 8), and eYFP controls (n = 7).
Two-way ANOVA (group 3 nose port) interaction F(2,44) = 4.482, p < 0.05; **p < 0.01 post hoc. (Inset) Active nose pokes on 3 consecutive days of testing.
(D) Percentage of time spent on laser side in a real-time place preference task. One-way ANOVA F(2,22) = 11.24, p < 0.001; **p < 0.01, ***p < 0.001 post hoc.
(E) Nonserotonin DRN stimulated mice (n = 6) were tested for nose-poke optical self-stimulation 30 min after injection of vehicle or 5-hydroxytryptophan (5-HTP;
40 mg/kg i.p.), the intermediate in the serotonin synthesis pathway. 5-HTP is the product of the enzyme tryptophan hydroxylase, which is knocked out in
ChR2-positive cells of these mice.
(F) Cumulative-activity graph of nose pokes in test sessions after injection of vehicle or 5-HTP. Individual data points were normalized to percent of nose pokes
achieved during a 30 min baseline session on day 1.
(G) Nonserotonin DRN stimulated mice (n = 6) were tested after injection of the dopamine D1 receptor antagonist SCH23390 (SCH; 30 mg/kg, i.p.) at either 15 or
30 min before testing.
(H) Cumulative-activity graph of active nose pokes in 30 min sessions following injection of saline or SCH.
(I) Active nose pokes during 5 min bins at the beginning or in the middle of test depicted in (H). Individual data points were normalized to the percentage of
responses during baseline day. Repeated-measures ANOVA (drug 3 epoch) interaction F(2,15) = 4.560, p < 0.05; ***p < 0.001 Dunnett’s post hoc versus saline
(see also Figures S3 and S4).promote reward-related behavior by disinhibiting mesolimbic
circuitry. To test the ability of DRN GABA neurons to reinforce
behavior, we injected cre-ON vectors expressing ChR2-eYFP
or eYFP alone into the DRN of VgatiCre mice (Figure 4E). Out
of 1,059 eYFP-positive neurons counted in DRN tissue from
three mice, less than 1% of cells also labeled for tyrosine hy-
droxylase or serotonin. Stimulation of these neurons did not
result in significant nose-poke behavior (Figures 4F and 4G),
but it did induce a statistically significant real-time place prefer-Cell Reence (Figure 4H). To the extent that optical stimulation of DRN
GABA neurons activates local inhibitory interneurons (Challis
et al., 2013), this result is consistent with studies showing that
local inhibition of the DRN can produce reward-related behavior
in rats (Fletcher et al., 1993; Liu and Ikemoto, 2007). However,
the lack of nose-poke behavior indicates that the rewarding
effects of these neurons are minimal in the mouse, and they
are not capable of driving the vigorous self-stimulation seen
previously (Figure 3C).ports 8, 1857–1869, September 25, 2014 ª2014 The Authors 1861
Figure 4. Optogenetic Stimulation of Dopaminergic or GABAergic DRN Cell Bodies Fails to Reinforce Nose-Poke Self-Stimulation
(A) DRN dopamine neurons were targeted by injecting cre-induced (‘‘cre-ON’’) vectors expressing ChR2-eYFP (n = 10) or eYFP (n = 14) into the DRN of THiCre
mice. The inset shows eYFP (green) double-labeled with tyrosine hydroxylase (TH, red).
(B) Nose pokes in the first day of testing.
(C) Active nose pokes on 3 consecutive days of testing.
(D) Percentage of time spent on laser side in real-time place preference task.
(E) DRN GABA neurons were targeted by injecting cre-ON ChR2-eYFP (n = 8) or eYFP (n = 4) into the DRN of VgatiCre mice. The inset shows eYFP (green) cell
bodies in the lateral DRN, which do not colabel for serotonin (5-HT, red) or tyrosine hydroxylase (TH, blue).
(F–H) Laser stimulation did not reinforce nose poke self-stimulation (F and G) but did induce a real-time place preference (H); *p < 0.05. (Scale bars, 200 mm).Distribution of Serotonergic and Nonserotonergic
DRN Projections
To explore potential interactions of the DRN with mesolimbic
reward circuitry, we examined the ascending projections of
both serotonergic and nonserotonergic DRN neurons. We con-
structed a cre-OFF viral vector (Figure 5A) containing a loxP-
flanked ChR2-eYFP coding region, thereby expressing eYFP
in the absence, but not in the presence, of cre recombinase
(Figure 5B). To visualize serotonergic and nonserotonergic pro-
jections within the same mice, we injected cre-OFF ChR2-eYFP
vector into the DRN of mice containing the serotonergic ePet-
cre transgene and the cre-induced TdTomato fluorophore
(ePet-cre; ROSA26fsTdTomato; Figure 5C). In these double trans-
genic mice, serotonergic cre-expressing neurons should ex-
press TdTomato but not eYFP. All other transduced neurons
within the DRN should express only eYFP. Tissue was collected
beginning at 12 weeks after surgery to allow sufficient time
for protein to fill distal processes. Red and green fluores-
cence within the DRN segregated into separate populations of
cre-positive (serotonergic) and cre-negative (nonserotonergic)
DRN cells (Figure 5C). Nonserotonergic (eYFP) projections
were seen emanating rostoventrally from the DRN; this tract split
bilaterally and entered the VTA, where it overlapped strongly
with tyrosine hydroxylase-positive cell bodies of the lateral
VTA (Figure 5D). This was the strongest site of eYFP expression
outside of the DRN (Figure 5E). Faint eYFP expression was seen
in a limited number of structures in the anterior brain, including1862 Cell Reports 8, 1857–1869, September 25, 2014 ª2014 The Authe dorosolateral bed nucleus of the stria terminalis, lateral
septum, and nucleus accumbens. In contrast, serotonergic
(TdTomato) projections did not exhibit the same dramatic de-
gree of variability (Figure 5F). At the level of the VTA, seroto-
nergic projections appeared predominantly as a dense bundle
of ascending fibers, located medially to the dopaminergic
cells. These findings indicate that nonserotonergic neurons of
the DRN project robustly to the dopamine-rich region of the
lateral VTA.
To determine whether nonserotonergic, VTA-projecting neu-
rons reside within the traditional boundaries of the DRN, we
iontophoretically infused the retrograde tracer Fluoro-Gold into
the VTA or, for comparison, into the substantia nigra reticulata.
In VTA-infused mice, strong retrograde labeling was observed
medially within the DRN, concentrated at midrostral levels (Fig-
ures 6A and 6E). Very little was seen in themedian raphe nucleus,
similar to previous reports (Watabe-Uchida et al., 2012). Mice
infused with tracer into the substantia nigra reticulata showed
retrograde labeling that was tightly restricted to a small group
of neurons in the dorsal DRN (Figure 6B). While these neigh-
boring pathways both originated within the boundaries of the
DRN, the number of nonserotonergic DRN neurons projecting
to the VTA vastly outnumbered those projecting to the sub-
stantia nigra reticulata (Figures 6C and 6D). Thus, retrograde
and anterograde measures indicate that the DRN-VTA circuit is
a robust pathway comprised of primarily nonserotonergic neu-
rons, whose major output is the VTA.thors
Figure 5. Unlike Serotonergic Neurons,
Nonserotonergic DRN Neurons Preferen-
tially Project to the VTA
(A) Schematic of cre-silenced (‘‘cre-OFF’’) DNA
construct containing loxP-flanked ChR2-eYFP
coding region.
(B) Transduction of primary cultured rat neurons
with cre-OFF ChR2-eYFP viral vector produces
eYFP fluorescence (left) that is abolished in cells
cotransduced with a vector expressing cre re-
combinase (right); DAPI nuclear staining (blue) is
unaffected. The scale bar represents 100 mm.
(C) Transgenic mice coexpressing cre and
TdTomato in serotonergic neurons (ePet-cre;
ROSA26fsTdTomato, n = 4) were injected with cre-
OFF ChR2-eYFP into the DRN. The inset depicts
whole DRN tissue (scale bar, 200 mm) and detail
demonstrating segregation of TdTomato and
eYFP fluorescence into separate populations of
cells.
(D) Serotonergic (red) and nonserotonergic
(green) axons are visible in the VTA, identifiable by
tyrosine hydroxylase immunoreactivity (TH, blue).
The scale bar represents 200 mm.
(E and F) Quantitation of (E) eYFP and (F)
TdTomato fluorescence intensity in brain regions
with conspicuous eYFP expression. SNc, sub-
stantia nigra pars compacta; LSi, intermediate
portion of the lateral septum; BNST, bed nucleus
of the stria terminalis; RN, red nucleus; IPN, in-
terpeduncular nucleus; NAc, nucleus accumbens;
LSd, dorsal portion of the lateral septum; SNr,
substantia nigra reticulata; PFC, prefrontal cortex.Nonserotonergic DRN-VTA Pathway Mediates
Behavioral Reinforcement and Excites VTA
Dopamine Neurons
To determine if selective stimulation of DRN-VTA projections
was sufficient to reinforce behavior, we targeted ChR2 expres-
sion to the DRN of wild-type mice and implanted optical fibers
in the VTA (Figure 7A). Mice vigorously nose poked for stimula-
tion of the DRN-VTA pathway (Figures 7B and 7C), indicatingCell Reports 8, 1857–1869, Septhat DRN-VTA projections are sufficient
to drive reward-related behavior. The
lack of rewarding effects from stimulation
of DRN serotonin, dopamine, and GABA
cell bodies strongly suggests that this
rewarding DRN-VTA pathway contains
a glutamatergic component. To compare
glutamatergic contributions of seroto-
nergic and nonserotonergic DRN-VTA
projections, we used cre-ON and cre-
OFF vectors to express ChR2-eYFP in
SERTcre mice (Figure 7D). SERTcre and
ePet-cre mouse lines demonstrate
similar selectively for expression in sero-
tonergic neurons, as 90.3% of 651 total
eYFP-positive cells from five SERTcre
mice injected with cre-ON eYFP viruswere found to double label with tryptophan hydroxylase. How-
ever, preliminary results in TdTomato reporter mice suggested
greater penetrance of expression in serotonergic populations
with the SERTcre line (data not shown); therefore, we used these
mice in electrophysiology experiments to ensure that cre-OFF
viral expression was limited to nonserotonergic neurons. We
obtained whole-cell patch clamp recordings in horizontal
slices containing VTA tissue beginning 12 weeks after surgery.
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Figure 6. The Majority of DRN Cell Bodies that Project to VTA Are Nonserotonergic
(A and B) The retrograde tracer Fluoro-Gold was iontophoretically infused into the (A) VTA or (B) substantia nigra reticulata (n = 4 per group). (Left panels) Fluoro-
Gold (green) at infusion site, double labeled with tyrosine hydroxylase (TH) to label dopamine neurons (red). (Right panels) Retrograde-labeled cells in DRN,
double labeled with tryptophan hydroxylase (TpH) to label serotonin neurons (red). Scale bars represent 200 mm.
(C) Number of Fluoro-Gold-labeled cells in DRN tissue from mice injected with Fluoro-Gold in VTA or substantia nigra reticulata. Fluoro-Gold cells were grouped
by presence or absence of tryptophan hydroxylase double label (TpH+, TpH). Two-way ANOVA (region 3 TpH label interaction) F(1,12) = 34.11, p < 0.0001;
***p < 0.001 post hoc.
(D) Percent of Fluoro-Gold labeled cells double-labeling for tryptophan hydroxylase. ***p < 0.0001.
(E) Number of TpH (left) and TpH+ (right) Fluoro-Gold labeled cells across the rostrocaudal axis of the DRN. The x axis indicates location of DRN tissue, in
millimeters posterior to bregma.postsynaptic currents (EPSCs) in 34 of 43 cells tested (79.1%;
Figure 7F), with an average latency of 1.84 ± 0.15ms. Stimulation
of the serotonin pathway produced EPSCs in 21 of 47 cells
tested (44.7%), with an average latency of 2.51 ± 0.11 ms.
The rapid latency and low jitter of current response times
suggest monosynaptic connections. The magnitude of EPSCs
produced by stimulation of the nonserotonin pathwaywas signif-
icantly larger than those produced by the serotonin pathway
(Figure 7G). Bath application of selective a-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) and N-methyl-D-
aspartate (NMDA) antagonists completely abolished evoked
currents (Figure 7E). When light-responsive cells were tested
for action potentials in current clamp (Figure 7H), stimulation of
the nonserotonin pathway produced action potentials in 19 of
28 cells tested (67.9%; Figure 7I). The serotonin pathway
only produced spikes in 3 of 17 cells (17.6%). In addition, spike
fidelity was greater in response to optical stimulation of the non-1864 Cell Reports 8, 1857–1869, September 25, 2014 ª2014 The Auserotonin pathway (Figure 7J). These data demonstrate that non-
serotonergic, glutamatergic DRN neurons directly target VTA
dopamine neurons and are highly efficacious in enhancing their
rate of firing.
DISCUSSION
In the present study, we found that stimulation of DRN cell
bodies was capable of strongly reinforcing instrumental be-
havior, with a level of vigor comparable to direct stimulation of
VTA dopamine neurons. Although serotonergic neurons are the
largest population of projection neurons in the DRN, selective
stimulation of these cells did not reinforce behavior. Rather,
self-stimulation was preferentially elicited by targeting nonsero-
tonergic DRN neurons, which we showed to comprise the ma-
jority of DRN-VTA projections. Furthermore, stimulation of the
DRN-VTA pathway was sufficient to fully reinforce instrumentalthors
Figure 7. DRN-VTA Projections Reinforce Behavior and Provide Synaptic Glutamatergic Excitation of VTA Dopamine Neurons Primarily via
Nonserotonergic Projections
(A) Mice (n = 11) were injected with nonspecific ChR2 viral vector in the DRN and implanted with fiber optic cables in the VTA.
(B) Cumulative activity graph of nose pokes into active and inactive ports on the first day of training. Total number of responses was greater into the active port
(p < 0.01).
(C) Total number of active nose pokes on day 1 from DRN-VTA mice. For comparison, data are reconstituted from previous experiments stimulating serotonergic
and nonserotonergic DRN cell bodies.
(D) Serotonergic and nonserotonergic DRN projections were targeted by injecting cre-induced (‘‘cre-ON’’) (n = 6) or cre-silenced (‘‘cre-OFF’’) (n = 4) vectors
expressing ChR2-eYFP in SERTcre mice.
(E) Representative voltage-clamp traces of VTA dopamine neurons showing optically evoked glutamatergic EPSC resulting from stimulation of terminals of the
serotonergic (top trace) or nonserotonergic (bottom trace) DRN-VTA pathway.
(F) EPSC amplitudes in response to optical stimulation. Graph includes cells that did not respond to light (plotted as 0 pA).
(G) Average amplitude of light-responsive EPSCs, ***p < 0.0001.
(H) Representative current-clamp traces of a VTA dopamine neuron spiking in response to 20 Hz laser stimulation of DRN-VTA serotonin (left) or nonserotonin
(right) pathways.
(I) Individual spike fidelity measurements; represented as percent of laser pulses during a 0.5 s, 20 Hz train that resulted in action potentials.
(J) Average spike fidelity in cells that responded to light with at least one action potential, *p < 0.05.learning. Because self-stimulation was not supported by DRN
dopaminergic or GABAergic cell bodies, our observations sug-
gest that the rewarding effects of DRN stimulation are mediated
by nonserotonergic glutamate neurons. Accordingly, in vitro
stimulation of the nonserotonergic DRN-VTA pathway increased
VTA dopamine neuron firing rates and produced monosynaptic
glutamatergic currents that were substantially larger than those
elicited by stimulating the serotonergic pathway.Cell ReThe DRN contains the largest group of serotonergic neurons
in the brain, a subset of which encode information about the
magnitude of the reward received (Inaba et al., 2013; Liu et al.,
2014; Nakamura et al., 2008). We employed a variety of optoge-
netic and pharmacological methods to test the possibility that
such activity drives reinforcement learning. In all cases, the
results of our experiments did not support this conclusion.
This is consistent with reports that rats and primates do notports 8, 1857–1869, September 25, 2014 ª2014 The Authors 1865
self-administer serotonergic drugs (Go¨testam and Andersson,
1975; Griffiths et al., 1976), which we now extend to mice. In
both fenfluramine and optogenetic place preference experi-
ments, maximal trends toward rewarding effects were seen at
low doses/frequencies, suggesting that serotonin may exert
proreward effects in an inverted U-shaped manner. A recent
study demonstrated that optogenetic stimulation of serotonergic
DRNneurons inmice can reinforce a variety of instrumental tasks
(Liu et al., 2014). There were several methodologic differences
between this study and our present work that likely afforded
Liu et al. greater sensitivity in detecting behavioral effects of laser
stimulation that, in our experiments, produced nonsignificant
trends toward the same direction of effect. Nevertheless, using
identical behavioral and optical parameters across experiments,
we found that reinforcement learning was preferentially sup-
ported in this region by a population of nonserotonergic neurons.
Mice in our study vigorously nose poked for optogenetic
stimulation of nonserotonergic DRN neurons. This finding is
consistent with reports that rats will respond for electrical
DRN stimulation in a serotonin-independent manner (Margules,
1969; Rompre´ and Miliaressis, 1987; Simon et al., 1976; but
see Van Der Kooy et al., 1978). Although electrical self-stimula-
tion literature provides the foundation for our understanding of
brain reward circuitry, interpretation of this work is inherently
limited by the fact that electrical stimulation of brain tissue ex-
cites both cell bodies and axonal fibers. In fact, action potentials
are preferentially induced in axons, due to a far greater surface
density of sodium channels (Nowak and Bullier, 1998). This issue
is of particular importance because the DRN is bordered by
dense fiber tracts; furthermore, it receives strong projections
from several brain regions that are each individually sufficient
to support reward learning, including the lateral hypothalamus,
laterodorsal tegmental nucleus, and medial prefrontal cortex
(Britt et al., 2012a; Kempadoo et al., 2013; Lammel et al.,
2012; Lee et al., 2003). By using optogenetic methodology, we
are able to negate the influence of stimulating fibers and localize
the reward-relevant neuronal cell bodies.
Electrical mapping studies indicate that rewarding sites in the
brain are not restricted to the DRN, but extend rostrally in a
continuous band before bifurcating laterally and merging with
the VTA (Rompre´ and Miliaressis, 1985). We found that stimula-
tion of cell bodies rostral to the DRN did not produce behavioral
measures of reward, although we did observe efferent fibers of
DRN neurons in an identical pattern to the rewarding region
described. Thus, the rewarding effects of electrical stimulation
in this region are likely mediated by activation of axonal fibers
originating from nonserotonergic cell bodies in the DRN.
Furthermore, two-electrode collision experiments within this re-
gion suggest that the reward-relevant axons are highly branched
between VTA and DRN (Boye and Rompre´, 1996), suggestive of
the dense network of nonserotonergic fibers that we observed in
the VTA. The rewarding properties of DRN stimulation were
dependent on dopamine receptor activation. Although the
DRN contains dopaminergic cell bodies (Dougalis et al., 2012;
Lu et al., 2006), stimulation of these cells did not evoke
reward-related behavior, suggesting action on mesolimbic
dopamine circuitry. Accordingly, we found that nonserotonergic
DRN neurons primarily project to the VTA, with comparatively1866 Cell Reports 8, 1857–1869, September 25, 2014 ª2014 The Ausparse projections to the nucleus accumbens and other fore-
brain structures. Furthermore, stimulation of the DRN-VTA path-
way was sufficient to fully reproduce the rewarding effects of
DRN cell body stimulation. Although other projection targets
may contribute, these findings suggest that the DRN is capable
of driving reinforcement learning primarily through its projection
to the VTA.
Because individual stimulation of serotonergic, GABAergic,
and dopaminergic DRN cell bodies failed to reinforce behavior,
we infer that the rewarding effects seen in our nonserotonergic
stimulation experiment weremediated through a distinct popula-
tion of cell bodies. The largest remaining population of cells,
accounting for approximately 10% of DRN neuronal cell bodies,
are nonserotonergic neurons expressing vesicular glutamate
transporter 3 (Commons, 2009; Hioki et al., 2010). Indeed, we
observed that stimulation of the nonserotonergic DRN-VTA
pathway produced strong monosynaptic glutamatergic currents
and drove spiking activity in VTA dopamine neurons. Compara-
tively weak currents were observed following stimulation of the
serotonergic DRN-VTA pathway. Because direct excitation of
VTA dopamine neurons is sufficient to powerfully reinforce
instrumental learning (Witten et al., 2011), it seems reasonable
to propose that the rewarding effects of nonserotonergic DRN
stimulation were driven, at least in part, by a glutamatergic
DRN-VTA mechanism. However, the DRN is also noted to
contain several peptidergic cell types, including corticotropin-
releasing factor and substance P (Valentino and Commons,
2005). Although these peptides are aversive when administered
intracerebroventricularly (Cador et al., 1992; Elliott, 1988), we
cannot rule out the possibility that these or other DRN cell types
contribute to reinforcement learning. With these caveats in mind,
the most parsimonious interpretation of the data presented is
that this population of nonserotonergic glutamate neurons is
highly efficacious in driving reward-related behavior.
It has been shown that the DRN sends projections tomesolim-
bic circuitry, with the VTA receiving notably stronger innervation
than nucleus accumbens (Vertes, 1991). Retrograde studies
mapping whole-brain inputs to the VTA have noted the DRN
as a major input (Geisler et al., 2007; Phillipson, 1979; Watabe-
Uchida et al., 2012). None of these reports, however, examined
the serotonergic composition of this projection. Early studies of
DRN anatomy led to the view that nearly all of its projection neu-
rons are serotonergic (reviewed in Jacobs and Azmitia, 1992).
We have quantitatively compared the composition of the DRN-
VTA projections using anterograde, retrograde, and electrophys-
iological techniques. All three approaches supported the same
conclusion: the majority of this pathway consists of nonseroto-
nergic projections. Our study raises important questions and
opens new avenues of investigation with respect to the role of
this circuit in normal function and disease states.
EXPERIMENTAL PROCEDURES
Animals
Adult (8+ weeks) male and female mice were housed with food and water
available ad libitum. Mice were housed on a 12/12 hr light cycle with lights
on at 7:00 a.m. All experiments except intravenous self-administration were
carried out during the animals’ light cycle. Wild-type C57Bl6/J mice were or-
dered from Jackson Laboratories; transgenic mice were bred in house.thors
Transgenic expression of cre recombinase was achieved in serotonin neurons
using ePet-cre (Scott et al., 2005) or Sl6a4cre/+ mice, referred to herein as
SERTcre (Zhuang et al., 2005). ePet-cre mice were considered advantageous
for behavioral experiments (Figure 2) because SERTcremice are heterozygous
knockouts for the serotonin transporter, a manipulation that alters basal extra-
cellular serotonin levels (Mathews et al., 2004) and could possibly confound
behavioral data. Additionally, ePet-cre mice do not demonstrate ectopic cre
expression during early development like the SERTcre line (Scott et al., 2005;
Zhuang et al., 2005) and were therefore used to selectively induce recombina-
tion in serotonergic neurons for genetic fluorescent labeling (Figure 5). Dopa-
minergic and GABAergic neurons were targeted using THiCre/+ (Lindeberg
et al., 2004) and VgatiCre/+ (Vong et al., 2011) mice. Deletion of serotonin
synthesis was carried out in Tph2lox/lox mice (Wu et al., 2012). Cre-mediated
fluorescence was produced using ROSA26fsTdTomato/+ mice, which carry a
floxed stop cassette preceding a coding region for the TdTomato gene (Mad-
isen et al., 2010). All lines were backcrossed onto a C57Bl6/J background.
Mice were surgically injected with viral vectors (Table S1) and implanted
with fiber optic cables (Britt et al., 2012b), the details of which are described
in Supplemental Experimental Procedures. All animal procedures were
approved by the National Institute on Drug Abuse’s animal care and use com-
mittee and carried out in accordance with NIH Guide for the Care and Use of
Laboratory Animals.
Optogenetic Real-Time Place Preference
Mice were placed in a 24 3 36 cm plastic chamber with walls of opposite
halves identified by horizontal or vertical stripes and a small 0.5 cm barrier
on the floor at the division site. A cohort of naive wild-type mice tested in
these chambers did not display a preference for either side (51.8% ± 2.6%
preference for horizontally striped half; n = 6). Mouse movement was tracked
with Ethovision computer software (Noldus), and presence in the randomly
assigned laser-paired half resulted in 15 mW 473nm laser stimulation at
20 Hz, with 5 ms pulses. Mice remained in the chamber for 12 min. Electrical
self-stimulation studies indicate that the reward substrate within the DRN is
increasingly responsive to higher stimulation frequencies, with reward thresh-
olds occurring within the range of 13–40 Hz, depending on electrode place-
ment (Rompre´ and Miliaressis, 1985). ChR2 protein is capable of inducing
action potentials in a variety of neuron types up to 20 Hz, above which spike
fidelity is less reliable (Tye and Deisseroth, 2012). Therefore, in the present
study, 20 Hz optogenetic stimulation was used to drive action potentials in
serotonergic and nonserotonergic DRN cells (Figure S2). Although seroto-
nergic DRN neurons typically have baseline firing rates below 5 Hz, they
were recently shown to briefly fire at 20–30 Hz during a reward task (Liu
et al., 2014). DRN serotonin neurons are capable of following extrinsic
20 Hz stimulation without entering depolarization block, as assessed with
whole-cell patch clamp (Figure S2) and in vivo microdialysis (Sharp et al.,
1989).
Optogenetic Nose-Poke Self-Stimulation
One week after the place preference task, mice were allowed to self-stim-
ulate by performing a nose-poke instrumental response (Stuber et al.,
2011). On a habituation day, mice were placed in operant chambers (Med
Associates) for 45 min with ports closed off to prevent access. Mice were
then given access to ports for 3 days of testing. Mice were placed in the
chamber for 1 hr. A nose poke into the active port resulted in a 3 s train
of laser pulses (30 mW for midline DRN stimulation, 2 3 15 mW for bilateral
VTA stimulation) at 20 Hz with 5 ms pulses, accompanied by dimming of the
house light and an auditory cue. Nose pokes during the 3 s stimulation
period had no consequence and were not counted toward the active
nose poke total.
Electrophysiology
Details of procedures and recipes can be found in supplemental methods.
Briefly, cells within 250 mm slices of tissue containing DRN or VTA were re-
corded in whole-cell patch clamp using a potassium gluconate-based internal
solution. VTA dopamine cells were identified by morphology, tonic spike rate,
and presence of a hyperpolarization-induced Ih current, which can be a
reasonable predictor of dopaminergic identity in mice (Margolis et al., 2006;Cell ReWanat et al., 2008; Zhang et al., 2010). Cells were optically stimulated with
473 nm laser light, directed at tissue through a fiber optic cable submerged
in the bath and aimed at the region of interest.
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